NCT06642610Completed
CGM Dynamic Index for Predicting Prediabetes in Cystic Fibrosis
CGM Dynamic Index (CDI) for Predicting Prediabetes in People With Cystic Fibrosis
Source: ClinicalTrials.gov · Last updated 17 Sept 2026
Brief summary (registry, in English)
The primary objective of this pilot study is to develop a CGM-based model to predict the progression from prediabetes to diabetes in individuals with cystic fibrosis.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 14 (actual)
- First submitted
- 10 Oct 2024
- Start date
- 15 Jun 2025
- Primary completion date
- 30 Jun 2026
- Lead sponsor
- Indiana University
- Diseases
- Cystic fibrosis
- NCT number
- NCT06642610
What you commit to
- Study type: Interventional
- Participants enrolled: 14
- From 15 Jun 2025 to the primary completion date, 30 Jun 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Use of immunosuppressant drugs.
Other illness
- History of transplant.
- Allergy to adhesives.
- Conditions that may make unsafe for participants to do study or impair or confound the study at the discretion of the investigator
Lab values
- Use of oral steroids or any medication known to interfere with glucose.
- Individuals with severe concurrent medical conditions that could confound glucose monitoring data (e.g., terminal illness, major organ failure).
Other
- Pregnancy.
Who the study is looking for
- CF individuals aged 12-55 years.
- CF without diabetes or with prediabetes (as defined by OGTT and HbA1c).
- Willing to use a continuous glucose monitoring system with compatible smart phone for glucose data collection.
- A person with CFRD and already using CGM, we will just collect their personal CGM data, and they are not required to have OGTT or HbA1c visit.
Age in the registry: 12 years to 55 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Indiana University Health University Hospital Coordinator of this site? Confirm its status | Indianapolis | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.